Abstract 499
Case Summary
Colonic perforation after stent placement is generally occurs in early phases, within 72 hours, whereas delayed perforations, which we define a perforation over 72 hours after stent placement, have been rarely described. A 76-year-old man, who had undergone stent placement for sigmoid colon obstruction 30 days before and discussed to undergo surgery at the outpatient care, presented sudden lower abdominal pain. He was diagnosed a lower gastrointestinal perforation and we planned to perform emergent surgery. In the operation, we recognized a large amount of stool odor ascites and a perforation from the sigmoid colon. We performed Hartmann procedure. At the gross findings of a specimen, the perforation was the junction areas between normal bowel wall and the tumor. He was discharged uneventfully at postoperative 29 day. Delayed colonic perforation after stent placement may be caused by the weakening of junction areas between normal bowel wall and the tumor or by tumor perforation due to mechanical tumor necrosis arising from stent and wire problems. Our case was the former. Delayed perforation is rare, but we cautiously take care of it long-term after stent placement
Editorial acknowledgement
Clinical trial identification
Resources from the same session
905 - Dose distribution in coronary arteries in left-sided breast cancer treated with Radiotherapy
Presenter: Umesh Velu
Session: Poster display - Cocktail
Resources:
Abstract
1060 - Metabolic Syndrome in Luminal-Type Non-Metastatic Breast Cancer during Hormonal Treatment Does it really have impact on prognosis?
Presenter: Kartika Taroeno-Hariadi
Session: Poster display - Cocktail
Resources:
Abstract
1148 - High Eosinophils Lymphocyte Ratio (ELR) Related With Subtype of Breast Cancer in Sanglah General Hospital, Bali
Presenter: Anak Agung Lestari
Session: Poster display - Cocktail
Resources:
Abstract
400 - Ribociclib (RIB) + endocrine therapy (ET) in Japanese women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC)
Presenter: Norikazu Masuda
Session: Poster display - Cocktail
Resources:
Abstract
801 - Osteopontin Level and Promoter Polymorphism is Associated with Aggressiveness in Breast Cancer
Presenter: Mohamed Elbaiomy
Session: Poster display - Cocktail
Resources:
Abstract
1014 - Global Clinical Trials Validating Bioequivalence with China-Manufactured Trastuzumab Biosimilar, HLX02, and Herceptin®
Presenter: Quanying Zhang
Session: Poster display - Cocktail
Resources:
Abstract
1138 - Circular RNA NCAPG promotes breast cancer metastasis through acting as the sponge of miR-200s
Presenter: Yunjie He
Session: Poster display - Cocktail
Resources:
Abstract
145 - Repeat biopsy a must in recurrent breast cancer: A study from tertiary cancer centre in India.
Presenter: Abhishek Anand
Session: Poster display - Cocktail
Resources:
Abstract
804 - Meta-analysis of four Phase 3 RCTs of tamoxifen, versus 3rd generation aromatase inhibitors as 1st Line Endocrine Therapy for HR+ Advanced Breast Cancer
Presenter: John Robertson
Session: Poster display - Cocktail
Resources:
Abstract
1154 - Estimation of efficacy and safety of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in recurrent or metastatic breast cancer patients
Presenter: Sung Soo Kang
Session: Poster display - Cocktail
Resources:
Abstract